BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 81636)

  • 21. [Immunostimulative therapy of herpes zoster (three years' experience with inosiplex) (author's transl)].
    Bunta S; Peris Z
    Z Hautkr; 1981 Nov; 56(22):1457-66. PubMed ID: 6171939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients.
    Jones CE; Dyken PR; Huttenlocher PR; Jabbour JT; Maxwell KW
    Lancet; 1982 May; 1(8280):1034-7. PubMed ID: 6176821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of inosiplex on the humoral and cell-mediated immune responses to intradermal human diploid cell rabies vaccine.
    Sriwanthana B; Phanuphak P; Thaweepathomwat M; Warrell MJ; Warrell DA; Suntharasamai P; Baer GM
    Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):543-9. PubMed ID: 2437660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoprinosine in classical acute viral hepatitis.
    Lam KC; Lin HJ; Lai CL; Lam SK; Kwan YL
    Am J Dig Dis; 1978 Oct; 23(10):893-6. PubMed ID: 82401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inosiplex: an immunomodulation model for the treatment of viral disease.
    Ginsberg T; Glasky AJ
    Ann N Y Acad Sci; 1977 Mar; 284():128-38. PubMed ID: 81634
    [No Abstract]   [Full Text] [Related]  

  • 26. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds.
    Farr BM; Conner EM; Betts RF; Oleske J; Minnefor A; Gwaltney JM
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1183-7. PubMed ID: 2820298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inosiplex: a novel treatment in rheumatoid arthritis?
    Wybran J; Famaey JP; Appelboom T
    J Rheumatol; 1981; 8(4):643-6. PubMed ID: 6170755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex.
    Dyken PR; Swift A; DuRant RH
    Ann Neurol; 1982 Apr; 11(4):359-64. PubMed ID: 6179455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inosiplex for SSPE.
    Jones C
    Lancet; 1982 Aug; 2(8296):495. PubMed ID: 6180266
    [No Abstract]   [Full Text] [Related]  

  • 30. Inosiplex for SSPE.
    Chalmers TC; Smith H
    Lancet; 1982 Jun; 1(8287):1475. PubMed ID: 6177984
    [No Abstract]   [Full Text] [Related]  

  • 31. Study of the antiallergic component of inosine pranobex (Inosiplex, Isoprinosine).
    Schmutzler W; Neukirch B; Ziesche R
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):244-6. PubMed ID: 2468618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Double-blind clinical trial of isoprinosine and placebo in herpetic keratitis].
    Haut J; Debrat G; Moulin F; Monin C; Sarnikovski C
    Bull Soc Ophtalmol Fr; 1983 May; 83(5):617-20. PubMed ID: 6200245
    [No Abstract]   [Full Text] [Related]  

  • 33. Progressive CT abnormalities despite clinical improvement in SSPE treated with inosiplex.
    Noetzel MJ; Dodson WE
    Ann Neurol; 1983 Apr; 13(4):457-60. PubMed ID: 6188412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Potentiation of cytotoxic effects of 5-fluorouracil by inosiplex on cancer cells].
    Miyoshi T; Ogawa S; Nobuhara M; Namba M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):440-4. PubMed ID: 6200078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inosiplex, a stimulating agent for normal human T cells and human leukocytes.
    Wybran J; Govaerts A; Appelboom T
    J Immunol; 1978 Sep; 121(3):1184-7. PubMed ID: 80429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis--a multi-institutional collaborative study--The Inosiplex-SSPE Research Committee.
    Fukuyama Y; Nihei K; Matsumoto S; Ebina T; Kamoshita S; Sato T; Arima M; Yabuuchi H; Ueda S; Ohtahara S
    Brain Dev; 1987; 9(3):270-82. PubMed ID: 2444125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of inosiplex on the survival of subacute sclerosing panencephalitis.
    DuRant RH; Dyken PR
    Neurology; 1983 Aug; 33(8):1053-5. PubMed ID: 6192362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isoprinosine: an overview.
    Simon LN; Glasky AJ
    Cancer Treat Rep; 1978 Nov; 62(11):1963-9. PubMed ID: 83189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical studies of the therapeutic effectiveness of the preparation Isoprinosine in herpetic keratitis].
    Prost M; Gerkowicz K; Kozak U
    Klin Oczna; 1986 Aug; 88(8):276-7. PubMed ID: 2437357
    [No Abstract]   [Full Text] [Related]  

  • 40. Systemic treatment of mollusca contagiosa with inosiplex.
    Gross G; Jogerst C; Schöpf E
    Acta Derm Venereol; 1986; 66(1):76-80. PubMed ID: 2424225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.